Publication | Closed Access

Dose selection using a semi-mechanistic integrated glucose-insulin-glucagon model: designing phase 2 trials for a novel oral glucokinase activator

Diabetes ManagementInsulin ManagementDiabetesPharmacologyDose SelectionDesigning Phase 2Blood Glucose MonitoringInsulin DeliveryMedicineArtificial PancreasDrug Discovery